Steele Robert Jc
University of Dundee, Chair, UK National Screening Committee , Dundee , UK.
Br J Radiol. 2018 Oct;91(1090):20180200. doi: 10.1259/bjr.20180200. Epub 2018 Apr 10.
Health screening can only be applied to populations, not individuals. For it to be effective, the initial screening test must be acceptable and reasonably accurate, the disease must be treatable with better outcomes when treated early and the harm and cost associated with screening must not outweigh its benefits. Robust evidence is therefore required before systematic screening is implemented. Surveillance implies the testing of people at high risk of disease and is therefore distinct from screening in both scale (smaller) and intensity (greater). In both cases, however, clear information must be provided to potential participants so that they can weigh up the balance of benefit and harm before deciding on whether or not to engage in the process.
健康筛查仅适用于人群,而非个体。要使其有效,初始筛查测试必须是可接受的且具有合理的准确性,疾病必须在早期治疗时疗效更佳,并且筛查相关的危害和成本不能超过其益处。因此,在实施系统筛查之前需要有力的证据。监测意味着对疾病高危人群进行检测,因此在规模(较小)和强度(更大)方面都与筛查不同。然而,在这两种情况下,都必须向潜在参与者提供清晰的信息,以便他们在决定是否参与该过程之前能够权衡利弊。